STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALAB
  4. [Form 4] Astera Labs, Inc. Insider Trading Activity

Astera Labs (ALAB) director receives 837 RSUs, total holdings now 92,482 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Astera Labs, Inc. director Michael E. Hurlston received an equity award of 837 shares of common stock in the form of restricted stock units (RSUs) on June 4, 2026. After this grant, he holds 92,482 shares directly, including deferred stock units and dividend equivalent units. The RSU award will vest in full on the earlier of the first anniversary of the grant date or the company’s next annual stockholder meeting, as long as he continues his service. Each RSU converts into one share of Astera Labs common stock when it vests.

Positive

  • None.

Negative

  • None.

Insights

Routine director RSU grant modestly increases equity alignment.

Director Michael E. Hurlston was granted 837 restricted stock units of Astera Labs, Inc. on June 4, 2026 under the company’s 2024 Stock Option and Incentive Plan. The award is a non-cash compensation grant and not an open-market purchase.

The RSUs vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent on continued service. This structure encourages ongoing board engagement while providing time-based equity incentives rather than immediate liquidity.

Following the grant, Hurlston directly holds 92,482 shares, including deferred stock units and dividend equivalent units. This filing reflects standard director compensation practice and does not, by itself, indicate a change in his market view of the stock.

Insider HURLSTON MICHAEL E.
Role null
Type Security Shares Price Value
Grant/Award Common Stock 837 $0.00 --
Holdings After Transaction: Common Stock — 92,482 shares (Direct, null)
Footnotes (1)
  1. These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Includes deferred stock units and dividend equivalent units.
RSU grant size 837 shares Restricted stock units granted on June 4, 2026
Grant price per share $0.00 per share Reported value for RSU award
Total shares after grant 92,482 shares Direct holdings following RSU award
Vesting trigger 1 year or next annual meeting RSUs vest at earlier of these dates
RSU-to-share ratio 1 RSU : 1 share Each RSU represents one common share upon vesting
restricted stock units ("RSUs") financial
"These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Astera Labs, Inc. 2024 Stock Option and Incentive Plan financial
"granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan"
deferred stock units financial
"Includes deferred stock units and dividend equivalent units."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
dividend equivalent units financial
"Includes deferred stock units and dividend equivalent units."
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
continuous service relationship financial
"subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HURLSTON MICHAEL E.
(Last)(First)(Middle)
C/O ASTERA LABS, INC.
2345 NORTH FIRST STREET
(Street)
SAN JOSE CALIFORNIA 95131
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026A837(1)A$092,482(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
2. Includes deferred stock units and dividend equivalent units.
Remarks:
/s/ Philip Mazzara, Attorney-in-Fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Astera Labs (ALAB) director Michael Hurlston report in this Form 4?

Director Michael E. Hurlston reported receiving 837 restricted stock units of Astera Labs common stock. The RSUs were granted as equity compensation and will convert into shares upon vesting, increasing his direct holdings rather than reflecting an open-market stock purchase.

How many Astera Labs (ALAB) shares does Michael Hurlston hold after this RSU grant?

After the June 4, 2026 RSU grant, Michael E. Hurlston holds 92,482 Astera Labs shares directly. This total includes his newly granted restricted stock units as well as deferred stock units and dividend equivalent units reported as part of his equity position.

What are the vesting terms of Michael Hurlston’s RSU award from Astera Labs (ALAB)?

The 837 restricted stock units vest in full on the earlier of the first anniversary of the June 4, 2026 grant date or the next annual stockholder meeting. Vesting requires Hurlston to maintain a continuous service relationship with Astera Labs through the applicable vesting date.

Does Michael Hurlston’s Astera Labs (ALAB) Form 4 show a stock purchase or sale?

The Form 4 reports an equity grant, not a market trade. Hurlston received 837 restricted stock units as compensation at a reported price of $0.00 per share, so there is no open-market buying or selling activity disclosed in this filing.

What plan governs Michael Hurlston’s new RSUs in Astera Labs (ALAB)?

The 837 restricted stock units were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. This plan provides the framework for equity-based awards, including RSUs that convert into one share of common stock for each unit upon vesting.

What do the deferred stock units and dividend equivalent units mean in Hurlston’s ALAB holdings?

His reported total of 92,482 shares includes deferred stock units and dividend equivalent units. Deferred stock units typically convert to shares at a future date, while dividend equivalent units track dividends on underlying awards, both contributing to his overall equity exposure to Astera Labs.